FSENX | RYESX | FSENX / RYESX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 44 years | 20 years | - |
Gain YTD | 8.628 | 9.608 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.92B | 11.5M | 16,730% |
Annual Yield % from dividends | 1.72 | 0.00 | - |
Returns for 1 year | 18.69 | 8.73 | 214% |
Returns for 3 years | 58.97 | 30.58 | 193% |
Returns for 5 years | 98.64 | 15.76 | 626% |
Returns for 10 years | 62.31 | -56.86 | -110% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FERIX | 48.89 | 0.64 | +1.33% |
Fidelity Advisor Emerging Asia I | |||
FGIRX | 42.36 | 0.35 | +0.83% |
Fidelity Advisor Growth & Income A | |||
JIEZX | 18.69 | 0.09 | +0.48% |
JPMorgan International Equity R2 | |||
MSBQX | 11.74 | 0.03 | +0.26% |
Morgan Stanley American Resilience R6 | |||
RCGHX | 16.49 | N/A | N/A |
Virtus KAR Health Sciences C |